About Simulations Plus, Inc.
Simulations Plus, Inc. develops absorption, distribution, metabolism, excretion, and toxicity modeling and simulation software for the pharmaceutical and biotechnology, industrial chemicals, cosmetics, food ingredients, and herbicide industries. In September 2014, the company acquired Cognigen Corporation, a provider of clinical trial data analysis and consulting services.
2BB score and signals
Simulations Plus, Inc.’s current 2BB score is 47 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|
| Activity | 33 | Low |
| Momentum | 37 | Weakening |
| Financial strength | 76 | Strong |
| Quality | 100 | Very Strong |
| Risk | 35 | Low |
Company facts
| Headquarters | Lancaster, California, United States |
| Founded | 1996 |
| Employees | 213 |
| P/E ratio | 45.77 |
| 52-week range | $11.09 – $21.01 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|
| 2027-01-06 | — | 0.0455 | — | $18.74M |
| 2026-11-30 | — | 0.0404 | — | $17.61M |
| 2026-07-09 | 0.18 | 0.1279 | $21.89M | $21.13M |
| 2026-04-09 | 0.22 | 0.1995 | $24.29M | $21.88M |
Related companies